首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >A Survey of Complementary and Alternative Medicine Use in Cancer Patients Treated with Radiotherapy in Thailand
【2h】

A Survey of Complementary and Alternative Medicine Use in Cancer Patients Treated with Radiotherapy in Thailand

机译:泰国对接受放射治疗的癌症患者补充和替代药物使用情况的调查

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Introduction. Use of complementary and alternative medicine (CAM) in cancer patients is increasingly acceptable worldwide, but most of the studies were surveyed from developed countries. In this study, we evaluated the first and large cohort of cancer patients with CAM use in Thailand. Materials and Methods. A self-administered questionnaire was completed by 248 cancer patients attending outpatient radiotherapy unit at Ramathibodi Hospital. Results. The prevalence of CAM use was 60.9%. The most frequently used CAM were dietary/vitamin supplements (56.9%). Independent predictors of CAM use were high income (P < 0.001) and cancer type (P = 0.019). About half of the patients (51%) reported positive effects from CAM use. Nevertheless, 9.4% of the patient also reported side effects. The majority of patients (58.3%) did not disclose their use of CAM to their doctors because they felt that it was not necessary for doctors to know (65.9%). The average spending for CAM use was 200 USD/month (range, 10–1,000). Conclusion. Although the cost for CAM is relatively expensive, the prevalence of CAM use in cancer patients in Thailand is high particularly, in patients with higher income. Therefore, all clinical oncologists should be concerned about the use of CAM during evaluation of the cancer patients.
机译:介绍。在世界范围内,癌症患者使用补充和替代医学(CAM)的接受程度越来越高,但是大多数研究是从发达国家进行的。在这项研究中,我们评估了泰国首例大规模使用CAM的癌症患者。材料和方法。一份由Ramathibodi医院的门诊放疗单元中的248名癌症患者填写的一份自我调查表。结果。 CAM的使用率为60.9%。最常用的CAM是膳食/维生素补充剂(56.9%)。 CAM使用的独立预测因素是高收入(P <0.001)和癌症类型(P = 0.019)。大约一半的患者(51%)报告说使用CAM有积极作用。尽管如此,仍有9.4%的患者报告了副作用。大多数患者(58.3%)没有向医生透露他们对CAM的使用,因为他们认为没有必要让医生知道(65.9%)。 CAM使用的平均支出为200 USD /月(范围10-1,000)。结论。尽管CAM的成本相对较高,但在泰国的癌症患者中,尤其是在高收入患者中,CAM的使用率很高。因此,在评估癌症患者时,所有临床肿瘤学家都应关注CAM的使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号